MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Diabetes & Endocrinology

Section

Diabetes & Endocrinology

958 articles

Ask AI
All specialtiesDiabetes & EndocrinologynewsClinical UpdatesCardiologyOncology

Latest updates

Diabetes & Endocrinology

Reevaluating TSH-FT4 Dynamics: New Evidence Challenges Traditional Reference Intervals

A retrospective study reveals that the TSH-FT4 relationship is segmented, not log-linear, with implications for refining thyroid function test interpretation and reference intervals.

Apr 22, 2026
Diabetes & Endocrinology

Hospital Delays in Glucose Checks and Insulin Dosing: Do They Impact Patient Care?

Study reveals significant time gaps between fingerstick glucose tests and insulin administration in hospitals, with nearly 30% of cases potentially receiving incorrect insulin doses due to changing glucose levels during delays.

Apr 22, 2026
Diabetes & Endocrinology

Somatostatin in the Gut: No Diabetes-Specific Patterns Found

New study reveals uniform distribution of somatostatin and its receptors throughout the intestinal tract in both healthy individuals and type 2 diabetes patients, challenging previous assumptions about its role in diabetes pathophysiology.

Apr 22, 2026
Diabetes & Endocrinology

Childhood BMI Trajectories Strongly Predict Adult Metabolic Multimorbidity: A 36-Year Cohort Study Reveals Life-Course Risk Patterns

A 36-year prospective study demonstrates that cumulative BMI burden from childhood to adulthood significantly elevates risks of metabolic multimorbidity, with distinct life-stage patterns and sex-specific vulnerabilities.

Apr 22, 2026
Diabetes & Endocrinology

Efficacy and Safety of Cagrilintide-Semaglutide Combination vs Semaglutide Alone for Weight Management in East Asian Adults with Overweight/Obesity: REDEFINE 5 Trial

Phase 3a trial in Japan/Taiwan shows cagrilintide-semaglutide combination delivers superior weight loss (18.4%) versus semaglutide alone (11.9%) in adults with overweight/obesity ± type 2 diabetes, with comparable safety profiles dominated

Apr 22, 2026
Diabetes & Endocrinology

Produce Prescription for Diabetes Falls Short in Improving Health Outcomes

A randomized trial found that a $80 monthly produce prescription did not significantly improve HbA1c levels or reduce healthcare utilization in diabetic patients at risk of food insecurity.

Apr 21, 2026
Diabetes & Endocrinology

Genetic Variant Modulates Dietary Impact on Glucose Control: Inuit Study Reveals Key Insights

A Greenlandic study shows that Inuit with a specific sucrase-isomaltase gene variant have better glucose regulation on a Western diet compared to non-carriers, suggesting potential new diabetes treatments.

Apr 18, 2026
Diabetes & Endocrinology

Validation of the 2025 ATA Risk Stratification System in a Cohort of Patients with Papillary Thyroid Carcinoma

A real-world study validates the 2025 ATA thyroid cancer risk guidelines, showing significant patient reclassification and identifying a new ‘low-intermediate-risk’ group needing tailored management approaches.

Apr 18, 2026
Diabetes & Endocrinology

2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts

A retrospective study of 670 papillary thyroid carcinoma patients validates the 2025 ATA risk stratification system, demonstrating a shift toward higher-risk classifications. The new ‘low-intermediate-risk’ class emerges as a di

Apr 18, 2026Sign in to read
Cardiology

No Clear Winner: Real-World Evidence Shows GLP-1RAs and SGLT2 Inhibitors Deliver Comparable Cardiovascular Benefits in Type 2 Diabetes

A large-scale multinational study of over 1.2 million patients reveals that individual GLP-1 receptor agonists and SGLT2 inhibitors offer broadly similar cardiovascular protection in type 2 diabetes, challenging assumptions about meaningful

Apr 18, 2026
Diabetes & Endocrinology

Genetic Variant in CUBN Gene Identified as Key Risk Factor for Metformin-Induced Vitamin B12 Deficiency

Researchers have identified a genetic variant in the cubilin gene (CUBN, rs1801222) that significantly increases the risk of metformin-induced vitamin B12 deficiency, with carriers of the AA genotype experiencing deficiency up to twice as f

Apr 17, 2026
Diabetes & Endocrinology

Testosterone-Augmented Exercise Shows Promise for Muscle Mass and Anemia in Spinal Cord Injury Patients

A 16-week home-based trial combining testosterone with functional electrical stimulation and arm ergometry improved lean mass and corrected anemia in spinal cord injury patients, though aerobic capacity gains were not statistically signific

Apr 17, 2026Sign in to read
Diabetes & Endocrinology

Maternal Diabetes and Early Neurodevelopment: Differential Risks Emerge Across Diabetes Types and Infant Sex

A nationwide cohort study of 466,462 infants reveals that maternal pregestational diabetes significantly increases the risk of delayed developmental milestones, with type 1 diabetes conferring the highest risk and female offspring showing p

Apr 17, 2026
Diabetes & Endocrinology

Three Modifiable Factors Predict Emotional Impairment in Thyroid Cancer Patients: What Clinicians Need to Know

A prospective study identifies exhaustion, head and neck discomfort, and body image concerns as independent predictors of poor emotional functioning in differentiated thyroid carcinoma patients. These findings highlight actionable targets f

Apr 13, 2026
Diabetes & Endocrinology

Rising Tide of Primary Hyperparathyroidism: Stockholm Study Reveals Dramatic Increase in Incidence and Prevalence Over 15 Years

A landmark population-based study spanning 2006-2020 in Stockholm, Sweden, reveals that biochemically confirmed primary hyperparathyroidism incidence increased by 52% while only half of affected patients received clinical diagnosis, highlig

Apr 13, 2026Sign in to read
Diabetes & Endocrinology

Surgical Metabolic Intervention: Bariatric Surgery Transforms Outcomes in Type 1 Diabetes With Obesity

A multicenter retrospective cohort study reveals that metabolic bariatric surgery in 162 adults with type 1 diabetes and obesity achieved 29.7% weight loss at one year, reduced insulin requirements by 57%, and significantly improved glycemi

Apr 13, 2026
Diabetes & Endocrinology

Semaglutide Shows Promise in Reducing Mental Illness Worsening in Patients with Depression and Anxiety, Swedish Study Finds

A landmark Swedish cohort study of 95,490 patients reveals that semaglutide is associated with a 42% lower risk of worsening mental illness in people with depression and anxiety, while other GLP-1 receptor agonists show varied effects. The

Apr 13, 2026
Diabetes & Endocrinology

Diabetic Retinopathy Severity Predicts Mortality Risk: Insights from the SOURCE Consortium

A retrospective cohort study of 524,687 diabetic patients reveals that increasing severity of diabetic retinopathy correlates with significantly higher mortality risk, with proliferative DR patients showing a 128% increased hazard of death

Apr 11, 2026
Diabetes & Endocrinology

Flash Glucose Monitoring Fails to Improve Glycemic Control but Reduces Large-for-Gestational-Age Risk in Gestational Diabetes

A randomized trial of 205 pregnant women with gestational diabetes found that adjunctive flash glucose monitoring did not improve time-in-range glucose measurements compared to standard self-monitoring. However, the device was associated wi

Apr 9, 2026Sign in to read
Diabetes & Endocrinology

Dairy-Enriched High-Protein Breakfast Enhances Circadian Gene Expression and Glycemic Control in Type 2 Diabetes

A randomized crossover trial demonstrates that a dairy-enriched diet with high-protein breakfast and early daytime carbohydrate restriction significantly upregulates circadian clock genes (BMAL1, REV-ERBα, CRY1), improves glycemic metrics i

Apr 7, 2026Sign in to read
Previous
24 / 25
1…22232425
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.